PL2504331T3 - Związek, jego nowe formy, zawierające je kompozycje farmaceutyczne i sposoby otrzymywania oraz zastosowanie - Google Patents
Związek, jego nowe formy, zawierające je kompozycje farmaceutyczne i sposoby otrzymywania oraz zastosowanieInfo
- Publication number
- PL2504331T3 PL2504331T3 PL10831161T PL10831161T PL2504331T3 PL 2504331 T3 PL2504331 T3 PL 2504331T3 PL 10831161 T PL10831161 T PL 10831161T PL 10831161 T PL10831161 T PL 10831161T PL 2504331 T3 PL2504331 T3 PL 2504331T3
- Authority
- PL
- Poland
- Prior art keywords
- compound
- preparation
- methods
- pharmaceutical compositions
- certain novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009101992592A CN102070618B (zh) | 2009-11-23 | 2009-11-23 | 一种化合物及其晶体 |
| PCT/CN2010/078997 WO2011060746A1 (en) | 2009-11-23 | 2010-11-23 | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use |
| EP10831161.4A EP2504331B1 (en) | 2009-11-23 | 2010-11-23 | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2504331T3 true PL2504331T3 (pl) | 2015-04-30 |
Family
ID=44029398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10831161T PL2504331T3 (pl) | 2009-11-23 | 2010-11-23 | Związek, jego nowe formy, zawierające je kompozycje farmaceutyczne i sposoby otrzymywania oraz zastosowanie |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US8658658B2 (pl) |
| EP (1) | EP2504331B1 (pl) |
| JP (1) | JP5758399B2 (pl) |
| KR (1) | KR101513784B1 (pl) |
| CN (2) | CN102070618B (pl) |
| AU (1) | AU2010321366B2 (pl) |
| BR (1) | BR112012012138B1 (pl) |
| CA (1) | CA2781066C (pl) |
| DK (1) | DK2504331T3 (pl) |
| ES (1) | ES2529105T3 (pl) |
| IN (1) | IN2012DN04868A (pl) |
| MX (1) | MX2012005926A (pl) |
| MY (1) | MY161749A (pl) |
| NZ (1) | NZ600266A (pl) |
| PH (1) | PH12012500992A1 (pl) |
| PL (1) | PL2504331T3 (pl) |
| PT (1) | PT2504331E (pl) |
| RU (1) | RU2507203C1 (pl) |
| WO (1) | WO2011060746A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102070618B (zh) * | 2009-11-23 | 2013-08-21 | 和记黄埔医药（上海）有限公司 | 一种化合物及其晶体 |
| MX383300B (es) * | 2014-06-19 | 2025-03-13 | Boehringer Ingelheim Animal Health Usa Inc | Composiciones parasiticidas que comprenden derivados de indol, metodos y usos de los mismos. |
| CN105985326B (zh) * | 2015-02-16 | 2020-04-14 | 上海宣创生物科技有限公司 | 嘧啶衍生物晶型ⅲ及其制备方法和用途 |
| WO2016187767A1 (en) * | 2015-05-25 | 2016-12-01 | Hutchison Medipharma Limited | Pharmaceutical compositions and use thereof |
| EP3541808A4 (en) * | 2016-11-18 | 2020-07-22 | Hutchison Medipharma Limited | SOLID TUMOR TREATMENT PROCESS |
| JP2020164434A (ja) * | 2019-03-28 | 2020-10-08 | 上野製薬株式会社 | ２，６−ナフタレンビス（２−オキサゾリン）の製造方法 |
| CN115052605B (zh) * | 2020-03-09 | 2024-07-05 | 和记黄埔医药（上海）有限公司 | 抗pd-1抗体和多受体酪氨酸激酶抑制剂的药物组合及其使用方法 |
| WO2022220519A1 (ko) * | 2021-04-12 | 2022-10-20 | 주식회사 미토이뮨테라퓨틱스 | 5-[(1,1-디옥시도-4-티오몰포리닐)메틸]-2-페닐-n-(테트라하이드로-2h-피란-4-일)-1h-인돌-7-아민의 신규 결정형 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0509299A (pt) * | 2004-03-30 | 2007-09-18 | Taisho Pharmaceutical Co Ltd | composto ou um sal, hidrato, ou solvato farmaceuticamente aceitável do mesmo, composição farmacêutica, e, métodos para a profilaxia ou o tratamento de doença, para reduzir ingestão de alimento de um indivìduo, para induzir saciedade em um indivìduo, para controlar ou reduzir ganho de peso em um indivìduo, para modular um receptor de mch em um indivìduo e para produzir uma composição farmacêutica |
| US20090149467A1 (en) | 2005-09-15 | 2009-06-11 | Merck & Co., Inc. | Tyrosine Kinase Inhibitors |
| NZ580671A (en) * | 2007-04-16 | 2012-03-30 | Hutchison Medipharma Entpr Ltd | Pyrimidine derivatives |
| CN101289444B (zh) * | 2007-04-16 | 2012-01-04 | 和记黄埔医药（上海）有限公司 | 一种嘧啶衍生物及其医药用途 |
| TW201008933A (en) * | 2008-08-29 | 2010-03-01 | Hutchison Medipharma Entpr Ltd | Pyrimidine compounds |
| CN102070618B (zh) * | 2009-11-23 | 2013-08-21 | 和记黄埔医药（上海）有限公司 | 一种化合物及其晶体 |
-
2009
- 2009-11-23 CN CN2009101992592A patent/CN102070618B/zh active Active
-
2010
- 2010-11-23 CA CA2781066A patent/CA2781066C/en active Active
- 2010-11-23 PL PL10831161T patent/PL2504331T3/pl unknown
- 2010-11-23 ES ES10831161.4T patent/ES2529105T3/es active Active
- 2010-11-23 JP JP2012539175A patent/JP5758399B2/ja active Active
- 2010-11-23 CN CN201080052921.2A patent/CN102648194B/zh active Active
- 2010-11-23 DK DK10831161.4T patent/DK2504331T3/en active
- 2010-11-23 PT PT108311614T patent/PT2504331E/pt unknown
- 2010-11-23 RU RU2012126112/04A patent/RU2507203C1/ru active
- 2010-11-23 IN IN4868DEN2012 patent/IN2012DN04868A/en unknown
- 2010-11-23 BR BR112012012138-3A patent/BR112012012138B1/pt active IP Right Grant
- 2010-11-23 EP EP10831161.4A patent/EP2504331B1/en active Active
- 2010-11-23 KR KR1020127015836A patent/KR101513784B1/ko active Active
- 2010-11-23 US US13/510,249 patent/US8658658B2/en active Active
- 2010-11-23 WO PCT/CN2010/078997 patent/WO2011060746A1/en not_active Ceased
- 2010-11-23 NZ NZ600266A patent/NZ600266A/en unknown
- 2010-11-23 MX MX2012005926A patent/MX2012005926A/es active IP Right Grant
- 2010-11-23 PH PH1/2012/500992A patent/PH12012500992A1/en unknown
- 2010-11-23 AU AU2010321366A patent/AU2010321366B2/en active Active
- 2010-11-23 MY MYPI2012002250A patent/MY161749A/en unknown
-
2013
- 2013-12-12 US US14/104,954 patent/US8946249B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL214822A0 (en) | Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof | |
| IL214175A (en) | Derivatives of aminotetralin, their pharmaceutical compositions and their use | |
| SG175037A1 (en) | Pharmaceutical composition | |
| SG175154A1 (en) | Pharmaceutical compositions | |
| EP2447253A4 (en) | DIHYDROPYRIMIDIN COMPOUNDS AND MANUFACTURING METHOD, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | |
| ZA201209739B (en) | Levocarrimycin,pharmaceutical compositions,preparation methods and uses thereof | |
| IL211018A (en) | Inhibitors, processes for making them, medicinal preparations containing them and their use | |
| EP2379077A4 (en) | PHARMACEUTICAL COMPOSITION | |
| PL2562172T3 (pl) | Pochodne sfelaktonu, ich kompozycje farmaceutyczne, sposoby wytwarzania i zastosowania | |
| IL216388A0 (en) | New compounds, pharmaceutical composition and methods relating thereto | |
| IL213452A0 (en) | Phenylpyrimidone compounds, pharmaceutical compositions, preparation methods and uses thereof | |
| IL207183A (en) | Dihydroindolone compounds, a process for their preparation and their pharmaceutical compositions | |
| PL2504331T3 (pl) | Związek, jego nowe formy, zawierające je kompozycje farmaceutyczne i sposoby otrzymywania oraz zastosowanie | |
| ZA201203531B (en) | Certain crystalline hydrates, pharmaceutical compositions thereof and methods for preparation and use thereof | |
| GB0902648D0 (en) | Pharmaceutical compounds and compositions | |
| IL219018A0 (en) | Pharmaceutical compositions | |
| ZA201105443B (en) | Novel saponin compounds,methods of preparation thereof,use thereof and pharmaceutical compositions | |
| EP2565180A4 (en) | ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE PRODUCTION METHOD AND PHARMACEUTICAL COMPOSITION THEREWITH | |
| GB0919650D0 (en) | Pharmaceutical composition | |
| GB0908317D0 (en) | Pharmaceutical compounds and compositions | |
| ZA201200165B (en) | 2-amino-2phenyl-alkanol derivatives, preparation thereof, and pharmaceutical compositions containing same | |
| IL189408A0 (en) | Siva3, its preparation and pharmaceutical compositions containing it | |
| GB0902428D0 (en) | Pharmaceutical methods & compositions | |
| GB0921139D0 (en) | Pharmaceutical methods & compositions | |
| GB0902651D0 (en) | Pharmaceutical compounds and compositions |